Product Information
PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.4092 per EA under NDC 42858070703. Its NADAC has been published 403 times since Nov 14, 2018.
FDA first approved this application on Jun 12, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858070703
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209293FDA Approved
6/12/2018
TE Code
AB
On Market Since
9/14/2018
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 403 times since Nov 14, 2018, and over the history we have for it it has declined 82.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4092 per EA |
|---|---|
| All-time high | $2.4367 (Mar 11, 2020) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.4047 |
| Median price | $0.9151 |
| Average price | $1.1158 |
| Largest weekly change | +50.9% (Feb 22, 2023) |
| Weeks tracked | 403 |
| Tracking since | Nov 14, 2018 |
1W
N/A
1M
0.0%
3M
+1.1%
6M
-15.5%
1Y
-16.5%
3Y
-46.5%
5Y
-65.5%
All
-82.0%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PAROXETINE HYDROCHLORIDE HEMIHYDRATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $0.4092 per EA (NDC 42858070703), effective Jul 29, 2026.
How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 82.0%. It has been tracked across 403 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?
Since Nov 14, 2018, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $2.4367 (Mar 11, 2020), with a median of $0.9151 per EA.
Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of PAROXETINE ER 37.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PAROXETINE ER 37.5 MG TABLET?
PAROXETINE ER 37.5 MG TABLET (NDC 42858070703) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.